Errata, Updates & Clarifications

For Health Care Providers

Highlights

Information updated for this version of the Pink Book.

Overview

Page 103, Diphtheria Toxoid-containing Vaccines; Page 246, Pertussis-containing Vaccines; Page 320, Tetanus Toxoid-containing Vaccines

The sentence describing the dose in the DTaP series for which Quadracel is licensed has been corrected and now reads: "DTaP-IPV (Quadracel) is licensed only for the fifth dose of DTaP and fourth or fifth dose of IPV among children age 4 through 6 years."

Content Source
National Center for Immunization and Respiratory Diseases (NCIRD); Immunization Services Division
About This Page
Published: July 16, 2024
Updated: March 19, 2024

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: March 22, 2024

The information on this page was last reviewed by subject matter experts to ensure accuracy.